Project 1: Enhancing the Economic Impact Analysis used in FDA's Rules p150-201

项目 1：加强 FDA 规则中使用的经济影响分析 p150-201

• 批准号: 8737855
• 负责人: MICHAEL PAUL ERIKSEN
• 金额: $ 88.75万
• 依托单位: GEORGIA STATE UNIVERSITY
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/8737855
• 关键词: Accounting; Addictive Behavior; Address; Adoption; Adult; Advertisements; Affect; Behavior; Behavioral; Birth; Canada; Categories; Child Mortality; Cigarette; Costs and Benefits; Country; Data; Data Analyses; Data Collection; Databases; Decision Making; Drops; Economic Policy; Economics; Exclusion; Exposure to; Future; Infant; Infant Mortality; Label; Lead; Low Birth Weight Infant; Myocardial Infarction; Outcome; Perception; Policies; Population; Pregnancy; Prevalence; Process; Public Health; Public Policy; Published Comment; Regulation; Research; Research Personnel; Research Priority; Research Project Grants; Role; Science; Self-control as a personality trait; Smoker; Smoking; Surveys; Time; Tobacco; Tobacco Smoke Pollution; Tobacco use; United States Food and Drug Administration; base; cigarette smoking; cigarette smoking; discounting; economic impact; economic implication; falls; health economics; improved; interest; maternal cigarette smoking; non-smoker; pleasure; public policy on tobacco; research study; smoking cessation; social; tobacco control; trend

As part of its rulemaking process, the U.S. Food and Drug Administration (FDA) is required to conduct an economic impact analysis that assesses the costs and benefits of proposed regulations and to select the option that maximizes the net economic benefit. There are numerous challenges inherent in conducting this type of analysis, from fully.assessing the various costs and benefits of proposed rules to quantifying these costs and benefits, often with incomplete data and evidence. The comments provided to FDA on the economic impact analysis contained in its proposed rule on required warnings for cigarette packages and advertisements highlighted these challenges. The overarching aim of this project is to produce new evidence that will inform and refine the FDA's economic impact assessments of future proposed rules. This will be done through a combination of behavioral economics experiments with original data collection, acquisition of existing archival, survey, and commercial databases, and merged data analyses that address the issues discussed above, as well as others that emerge in coming years. To accomplish this, a variety of . activities vvili be done to address three specific aims that together address most of the FDA's research priorities around understanding the role of economics and policies on tobacco use and perceptions. Aim 1: assess the impact of FDA regulatory actions and other tobacco control policies on tobacco use and related outcomes, including the impact on trajectories of tobacco use among young people and adults, the differential impact of these actions on disparate populations, and the differential impact on the use of traditional and emerging tobacco products. Aim 2: Assess the impact of FDA regulatory actions and other tobacco control policies on the consumer surplus obtained by tobacco users through a behavioral economics experiment that will quantify the extent of present bias, projection bias, and time inconsistencies in decisions about tobacco use and the implications of these biases for assessing changes in consumer surplus. Aim 3: Extend the range of costs and benefits including in assessing the economic impact of FDA regulatory actions to include a broader set of health and economic benefits than that included in previous FDA assessments.

作为其规则制定过程的一部分，美国食品药品监督管理局（FDA）必须进行 经济影响分析评估拟议法规的成本和收益，并选择 最大化净经济利益的选择。进行此挑战存在许多挑战 分析的类型，从完全。评估拟议规则的各种成本和收益以量化这些规则 成本和收益，通常具有不完整的数据和证据。提供给FDA的评论 其拟议规则中包含的经济影响分析对香烟套餐的要求警告和 广告强调了这些挑战。该项目的总体目的是生产新的 将为FDA对未来提议的规则的经济影响评估提供信息并完善FDA的证据。这 将通过行为经济学实验与原始数据收集的结合来完成 获取现有的档案，调查和商业数据库，并合并了解决的数据分析 上面讨论的问题以及未来几年中出现的其他问题。为此，各种各样。 进行活动VVILI以解决三个具体目标，共同解决大多数FDA研究 围绕理解经济学和政策在烟草使用和看法上的作用的优先事项。目标1： 评估FDA监管行动和其他烟草控制政策对烟草使用及相关的影响 结果，包括对年轻人和成人烟草使用轨迹的影响， 这些行动对不同人群的差异影响，以及对使用的不同影响 传统和新兴的烟草产品。目标2：评估FDA监管行动和其他的影响 烟草用户通过行为经济学获得的消费者盈余的烟草控制政策 实验将量化当前偏见，投影偏差和决策时间不一致的程度 关于烟草的使用以及这些偏见对评估消费者盈余变化的影响。目标3： 扩展成本和收益的范围，包括评估FDA监管行动的经济影响 包括比以前的FDA评估中包含的更广泛的健康和经济利益。